GENDER-BASED ANALYSIS OF ADVERSE EFFECTS OF DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES: A COMPARATIVE . Global Science Review, [S. l.], v. 2, n. 1, p. 418–422, 2025. Disponível em: https://global-science-review.com/ojs/index.php/gsr/article/view/238. Acesso em: 16 nov. 2026.